Market Dynamics:
The growth of the stem cell manufacturing market is majorly driven by the increasing prevalence of chronic diseases globally. As per WHO estimates, chronic disease death rates have increased by over 60% between 2000 and 2015. Cancer alone accounted for nearly 10 million deaths in 2020. Stem cell therapies offer a promising alternative for treating various chronic and degenerative conditions. Additionally, rising investments by both public and private players in stem cell research is also fueling the market growth. For instance, in 2022 National Institutes of Health funded over $400 million on stem cell research projects. However, concerns regarding ethical issues related to use of stem cells, especially embryonic stem cells limits the market potential.

Key Takeaways
The Global Stem Cell Manufacturing Market Size is expected to witness high growth, exhibiting a CAGR of 13.3% over the forecast period, due to increasing prevalence of chronic diseases. The market was valued at US$ 12415.84 Mn in 2023 and is projected to reach over US$ 39474.31 Mn by 2030.

Read More: https://newsinsights123.blogspot.com/2023/11/tissue-engineering-is-fastest-growing.html